ObsEva announced that its board of directors approved on December 8, 2022 an increase of its share capital through the issuance of 20,000,000 newly registered shares at an issue price of 1/13 of a Swiss Franc each. The 20,000,000 new shares, to be issued out of the company’s authorized capital, will be fully subscribed for by ObsEva USA Inc., its 100% wholly owned subsidiary, and listed on the SIX Swiss Exchange on or around December 12, 2022. The transaction has been decided to provide the group with additional treasury shares that can be used in the future to raise funds in an efficient manner, as well as for the equity plans of the company and its subsidiaries.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on OBSV:
- ObsEva To Increase Issued Share Capital by Creating Additional Treasury Shares
- ObsEva Announces Third Quarter 2022 Financial Results and Provides a Business Update
- ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million
- ObsEva Announces Progress on Cost Reduction Initiatives and Stay of Moratorium Proceedings
- ObsEva Announces IND Approval for Yuyuan Bioscience’s Phase 1 Clinical Trial of Nolasiban in China